Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.37 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 5/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526676 | 0.93 | POLB (0.48) | POLBGRIN1GRIN2AGRIA2CNR1 | |
| SCHEMBL31753684 | 0.91 | POLB (0.44) | POLBGRIN1GRIN2AGRIA2CNR1 | |
| SCHEMBL33527256 | 0.78 | LMNA (0.48) | POLBGAA | |
| SCHEMBL31752066 | 0.77 | TP53 (0.37) | POLBCNR2GAA | |
| SCHEMBL33526182 | 0.76 | L3MBTL1 (0.39) | POLBCNR2GAA | |
| SCHEMBL31753407 | 0.76 | GRN (0.41) | POLBCNR1CNR2 | |
| Hydrochloric Acid SCHEMBL33526972 | 0.76 | POLB (0.42) | POLBGRIN1GRIN2AGRIA2GAA | |
| SCHEMBL31753527 | 0.76 | TP53 (0.38) | POLBCNR1CNR2GAA | |
| SCHEMBL33526694 | 0.76 | TP53 (0.36) | POLBCNR2GAA | |
| SCHEMBL31752359 | 0.76 | TP53 (0.36) | POLBCNR2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | POLB 4745/4885GRIN1 1493/4885GRIN2A 1341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.